Multimodal therapy of carcinoma of the colon;Multimodale therapie des coloncarcinoms

Chirurg

Volumn 69, Issue 4, 1998, Pages 371-383

  Lehnert, Th ^a   Herfarth, Ch ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjuvant treatment; Chemotherapy; Colon cancer

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; COLON TUMOR; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE;

CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 0032037863     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050427     Document Type: Article

References (78)

1. Abdi EA, Hanson J, Harbora DE, Young DG, McPherson TA (1989) Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: a 7 year follow-up analysis. J Surg Oncol 40: 205
2. Adams W, Morris D (1994) Short-course cimetidine and survival with colorectal cancer. Lancet 344: 1768
3. Altomare DF, Lupo L, Pannrale OC, Corcia MG, Memeo V (1995) Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel. Eur J Surg 161: 109
4. Arnaud JP, Buyse M, Nordlinger B, Martin F, et al (1989) Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized trial. Br J Surg 76; 284
5. Brivio F, Lissoni P, Alderi G, Barni S, et al (1996) Preoperative Interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53: 263
6. Bury J, Focan C, Beauduin M, Herman ML, et al (1997) For the GRECCR Belgium. Portal and systemic chemotehrapy for Dukes' B2 and C colorectal cancer. An intermediary report on a double randomized trial. Proc ASCO 16: A942
7. Buyse M, Zelenuich-Jacquotte A, Chalmers TC (1988) Adjuvant chemotherapy of colorectal cancer: why we still don't know. JAMA 259: 3571
8. Chlebowski RT, Nystrom S, Reynolds R, Weiner JM, Bateman JR (1988) Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. Oncology 45: 141
9. Colorectal Cancer Chemotherapy Study Group of Japan (1995) Five year results of a randomized trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 25: 91
10. Dube S, Heyen F, Jenicek M (1997) Adjuvant chemotherapy in colorectal carcinoma. Results of a metaanalysis. Dis Colon Rectum 40: 35
11. Erlichman C, Marsoni S, Seitz JF, Skillings J, et al (1997) Event free and overall survival is increased by FUFA in resected B colon cancer: a pooled analysis of five randomized trials. Proc ASCO 16: A991
12. Falk RE, Makowka L, Ambus U, Falk JA, et al (1983) Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans. Can Med Assoc J 128: 1385
13. Francini G, Petrioli R, Lorenzini L, Mancini S, et al (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106: 899
14. Gastrointestinal Tumor Study Group (1984) Adjuvant therapy of colon cancer - results of a prospectively randomized trial. N Engl J Med 310: 737
15. Gastrointestinal Tumor Study Group (1991) Adjuvant therapy with hepatic irradiation plus fluorouracil in colon carcinoma. Int J Rad Oncol Biol Phys 21: 1151
16. Gilbert JM, Hellmann K, Evans M, Cassell PG, et al (1986) Randomized trial of oral adjuvant raxozane in resectable colorectal cancer: a five year follow-up. Br J Surg 73: 446
17. Graf W, Westlin JE, Pahlman L, Glimelius B (1994) Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colorect Dis 9: 35
18. Gray BN, Walker C, Andrewartha L, Freeman S, Bennett RC (1989) Controlled clinical trial of adjuvant immunotherapy with BCG and neuraminidase-treated autologous tumour cells in large bowel cancer. J Surg Oncol 40: 34
19. Gray R, Northover J (1996) Concerns about chemotherapy are legitimate. Br Med J 312: 1417
20. Grundmann R, Weber F, Kluger J, Wienand P, Pulverer G (1988) Präoperative unspezifische Immunstimulation mit Propionibacterium granulosum KP-45 bei Patienten mit colorectalem Carcinom. Chirurg 59: 272
21. Haller DG, Catalano PJ, Macdonald JS, Mayer RJ (1997) Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer: four year results of INT-0089. Proc ASCO 16: A940
22. Hermanek P jr, Wiebelt H, Riedl S, Staimmer D, et al (1994) Langzeitergebnisse der chirurgischen Therapie des Coloncarcinomes. Ergebnisse der Studiengruppe Kolorektales Karzinom (SGKRK). Chirurg 65: 287
23. Higgins GA, Amadeo JH, McElhinney J, McCaughan JJ, Keehn RJ (1984) Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and Methyl-CCNU following resection for carcinoma of the large bowel. Cancer 53: 1
24. Holden WD, Dixon WJ, Kuzma JW (1967) The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal cancer. Ann Surg 165: 481
25. Hoover HC, Brandhorst JC, Peters LS, Surdyke MG, et al (1993) Adjuvant active specific immunotherapy for human colorectal cancer: 6.5 year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 11: 390
26. IMPACT Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939
27. Ito K, Yamaguchi A, Miura K, Kato T, et al (1996) Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study group, the first study for colorectal cancer. J Surg Oncol 62: 4
28. Ito K, Yamaguchi A, Miura K, Kato T, et al (1996) Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study group - third study on colorectal cancer. J Surg Oncol 63: 107
29. Kingston RD, Fielding JWL, Palmer MK (1993) An evaluation of the effectiveness and safety of raxozane when used as an adjunct to surgery in colorectal cancer patients. Int J Colorect Dis 8: 106
30. Lacour J, Laplanche A, Malafosse M, Gallot D, et al (1992) Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal adenocarcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol 18: 599
31. Laurie JA, Moertel CG, Fleming TR, Wieand HS, et al (1989) Surgical adjuvant therapy of large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7: 1447
32. Lehnert Th, Herfarth Ch (1996) Grundlagen und Wert der Lymphadenektomie beim colorectalen Carcinom. Chirurg 67: 889
33. Link KH, Staib L, Bernhart H, Kreuser ED, et al (1997) Acceptance and toxicity of postoperative adjuvant therapy in colon and rectal cancers. Onkologie 20: 235
34. Lipton A, Scialla S, Harvey H, Dixon R, et al (1982) Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer. J Med 13: 419
35. Liver Infusion Meta-Analysis Group (1997) Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst 89: 497
36. Maeda K, Teramoto T, Watanabe M, Okuda M, Kitajima M (1996) Continuous infusion of fluorouracil into portal vein after curative resection of colorectal cancer. Jpn J Soc Coloproctol 49: 265
37. Mansour E, Ryan L, Lerner H, Comis R, et al (1989) Lack of effectiveness of 5-FU and Methyl CCNU as compared to 5-FU for adjuvante therapy in colon cancer: a randomized trial of the Eastern Soperative Oncology Group (ECOG)(EST2276). Proc ASCO 8: A447
38. Mantravadi RV, Miller M, Ashley LJ, Fisher W, et al (1990) Prophylactic 32P chromic phosphate therapy of the liver in completely resected modified Duke's stage C colon cancers. Proc ASCO 9: A444
39. Marangolo M, Pezzuoli G, Marubini E, Amadori D, et al (1989) Adjuvant chemotehrapy with fluorouracil and CCNU in colon cancer. Results of a multicentric randomized study. Tumori 75: 269
40. Matsumoto S (1995) Cimetidine and survival with colorectal cancer. Lancet 346: 115
41. Mitomi T, Tsuchiya S, Iijima N, Aso K, et al (1992) Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum 35: 123
42. Moertel CG, Fleming TR, McDonald JS, Haller DG, et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352
43. Moertel CG, Fleming TR, McDonald JS, Haller DG, et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Int Med 122: 321
44. Moertel CG, Fleming TR, McDonald JS, Haller DG, et al (1995) Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13: 2936
45. Nakazato H, Koike A, Sail S, Suzuki H, et al (1997) Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: a prospective randomized clinical trial. Proc ASCO 16: A990
46. Nauta R, Stablein D, Holyoke D (1989) Survival of patients with stage B2 colon carcinoma. Arch Surg 124: 180
47. Newland RC, Dent OF, Chapuis PH, Bokey L (1995) Survival after curative resection of lymph node negative colorectal carcinoma. Cancer 76: 564
48. Nio Y, Tsubono M, Tseng CC, Morimoto H, et al (1992) Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer. Biotherapy 4: 117
49. Nordlinger B, Bouteloup PY, Favre JP, Jaeck D, et al (1990) Early postoperative intraperitoneal chemotherapy (IPC) is feasible and well tolerated in colon cancer. A prospective randomized study. J Cancer Res 116: 686
50. O'Connell MJ, Maillard JA, Kahn MJ, Macdonald JS, et al (1997) Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15: 246
51. O'Connell MJ, Laurie JA, Kahn MJ, Fitzgibbons RJ, et al (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J ClinOncol 16: 295
52. Okuda M, Teramoto T, Watanabe M, Utsunomiya T, et al (1995) Adjuvant chemotherapy with Mitomycin C, Tegafur and UFT for colorectal cancer. J Jpn Soc Coloproctol 48: 120
53. Panettiere FJ, Goodman JP, Costanzi JJ, Cruz AB, et al (1988) Adjuvant therapy in large bowel adenocarcinoma: long-term results of a South West Oncology Group study. J Clin Oncol 6: 947
54. Papacostas P, Stathopoulos GP, Malamos NA, Michailakis E, et al (1998) 5-Fluorouracil plus leucovorin versus 5-FU leucovorin plus interferon - a given as adjuvant chemotherapy in colon cancer. Eur J Cancer 31A: S157
55. Reynolds JL, Akhter J, Adams WJ, Morris DL (1997) Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol 23: 224
56. Riethmüller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, et al (1994) Randomised trial of monoclocal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343: 1177
57. Riethmüller G, Holz E, Schlimok G, Schmiegel W, et al (1996) Monoclonal antibody adjuvant tehrapy of Dukes C colorectal carcinoma: 7-year update of a prospective randomized trial. Proc ASCO 15: A1385
58. Sahmoud T, Rougier P, Nitti D, Doci R, et al (1996) Adjuvant portal vein infusion of 5-FU and heparin (PVI) in colorectal cancer: an EORTC-GIVIO Inter-Group phase III trial. Ann Oncol [Suppl 5] 7: 33
59. Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y (1997) A meta-analysis of adjuvant therapy using oral fluoro-pyrimidines in patients with curatively resected colorectal carcinoma. Proc ASCO 16: A943
60. Salim AS (1992) Oxygen-derived free-radical scavengers prolong survival in colonic cancer. Chemotherapy 38: 127
61. Sause WT, Pajak TF, Noyes RD, Dobelbower R, et al (1994) Evaluation of preoperative radiation therapy in operable colorectal cancer. Ann Surg 220: 668
62. Scheithauer W, Kornek G, Rosen H, Sebesta C, et al (1995) Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. Eur J Cancer 31A: 1981
63. Schmoll HJ, Quietzsch D, Börner P, Kettner E, et al (1997) Safety of adjuvant mab 17-1A in colorectal cancer. Eur J Cancer [Suppl 8] 38: 750
64. Souter RG, Gill PG, Morris PJ (1982) A trial of nonspecific immunotherapy using systemic c. parvum in treated patients with Dukes B and C colorectal cancer. Br J Cancer 45: 506
65. Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, et al (1996) Postoperative chemotherapy for colorectal cancer by combinig 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer 77: 36
66. Swiss Group for Clinical Cancer Research (1995) Long-term results of single course adjuvant intraportal chemotherapy for colorectal cancer. Lancet 345: 349
67. Tønnesen H, Knigge U, Bülow S, Damm P, et al (1988) Effect of cimetidine on survival of gastric cancer. Lancet 2: 990
68. Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, et al (1990) Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation for colorectal cancer. Cancer Immunol Immunother 31: 261
69. Vermoerken JB, Claessen A, Gall H, van Holten A, et al (1997) Randomized phase III trial of active specific immunotherapy (ASI) versus control in patients with Duke's B2, B3 or C colon cancer. Eur J Cancer [Suppl 8] 38: 722
70. Villar-Grimalt A, Carrato A, Candel MT, Lizón J, et al (1991) Adjuvant treatment of high-risk colorectal adenocarcinoma (HRCRC) T3-4 N1-3 M0 (stage III) with 12 hrs continuous infusion 5-fluorouracil and BCNU. Proc ASCO 10: A490
71. Warczynski P, Gil J, Szmigielski S, Beuth J, Pulverer G (1997) Prevention of hepatic metastases by liver lectin blocking with D-galactose in colon cancer patients. A prospectively randomized clinical trial. Anticancer Res 17: 1223
72. Wiesenfeld M, O'Connell MJ, Wieand HS, Goncharoff NJ, et al (1995) Controlled clnical trial of Interferon-γ as postoperative surgical adjuvant therapy for colon cancer. J Clin Oncol 13: 2324
73. Willeke F, Lehnert Th (1998) Vincenz Czerny. Carrying concepts into the 21st century. Eur J Surg Oncol 23: 253
74. Windle R, Bell PRF, Shaw D (1987) Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. Br J Surg 74: 569
75. Wolmark N, Fisher B, Rockette H, Redmond C, et al (1988) Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 80: 30
76. Wolmark N, Rockette H, Fisher B, Wickerham DL, et al (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Cancer Protocol C-03. J Clin Oncol 11: 1879
77. Wolmark N, Rockette H, Mamounas EP, Jones J, et al (1996) The relative efficacy of 5-FU plus leucovorin, 5-FU plus levamisole and 5-FU plus levamisole plus leucovorin in patients with Dukes' B and C acrcinoma of the colon: first report of NSABP C-04. Proc ASCO 15: A460
78. Wunderlich M, Schiessel R, Rainer H, Rauhs R, et al (1985) Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure. Br J Surg [Suppl] 72: S107